Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Learn the long-term average annual return for index funds and how it informs portfolio construction, diversification, and risk management.
27,739 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
IMAX stock jumped this week as takeover chatter surfaced. This article breaks down the drivers behind the move, what ...
Investors wonder about the path ahead for Lucid stock. This guide lays out three scenarios, the key drivers, and conc...
Workday delivered a stronger-than-expected earnings beat, but the market fixated on AI-driven demand shifts that coul...
Transcat just posted its Q3 2026 results, revealing a mix of revenue gains and margin pressures. This analysis decode...
Hyperliquid Strategies’ billion hype treasury trade moves into public markets, as liquidity remains untested and inve...
IonQ faces a pivotal year as government and enterprise demand grows for quantum hardware and software. Analysts outli...
The latest move in Bath Body Works stock has traders buzzing. This article breaks down what sparked the rally, how it...
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Insider moves can reveal much about a company’s outlook, but they aren’t a single data point. This article breaks dow...
A handful of female CFOs at major tech firms are directing the era’s biggest AI infrastructure push. This piece expla...
SK hynix's IPO opened with fanfare but quickly cooled, echoing a SpaceX pattern. Investors are weighing whether the p...